Company executives provide updates on cancer treatment pelareorep and other elements of the company’s pipeline.
Mike Hollan
Advertisement
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.
Articles by Mike Hollan
The Project Farma president discusses various ways the tariffs could impact the industry and how businesses can prepare or react.
A panel discussion at the Global Life Science Partnering and Investor Conference discusses various strategies and trends in pharma investing.
Immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics, discusses the promise of harnessing natural killer cells to reshape treatment for cancer and autoimmune disease.
A look at the current landscape and how young companies can set the stage for product launch.
Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.
The prospective study reportedly showed an improvement of over 10%.
EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship with patients and new technology.
eHealth’s latest survey reveals Americans give the nation’s healthcare system a low grade and are open to significant changes.
Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales reps.
March is Colorectal Cancer Awareness Month, and the health plan hopes to improve survival rates with early screenings.
Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.
The data analytics company based its new product on simple spreadsheet technology.
Dr. Hernan Bazan, CEO of South Rampart Pharma, discusses his company’s current pipeline.
Three of the new sites will focus primarily on producing ingredients for domestic usage.
The Alpha Cognition executive discusses recent developments that positively impact the upcoming launch for ZUNVEYL.
The actor is leading a campaign focused on joint pain.
The YouScript CEO discusses new FDA guidance.
The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain stable.
The CEO discusses his company’s platform that helps reformulate oral solid dose medications to liquid forms.
John Arena, interim president of global pharma services at Cencora, discusses how new technologies are shortening timelines.
Anonymous reports claim the decision came from new leadership at HHS.
John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as early as possible during development in order to achieve a smooth product launch.
The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities.
The Blitz the Barriers initiative aims to reduce disparities among prostate cancer patients.
John Arena, interim president of global pharma services at Cencora, discusses how companies must prepare for each market and its unique regulatory requirements.
Former leaders of the CDC, FDA, and other agencies condemned the layoffs.
James Foster, CEO and co-founder of Virax Biolabs, discusses how global launches are being impacted by changing geopolitical conditions.
John Arena, interim president of global pharma services at Cencora, discusses how companies can continue to develop launch strategies while taking potential regulatory changes into consideration.
How one Big Pharma ad campaign is incorporating diversity as a driving force in improving the ways drugs are marketed directly to the patients that need them.
Advertisement